Vav1m1Anu/Vav1m1Anu
C57BL/6JAnu-Vav1m1Anu
|
increased T cell number |
J:104190
|
Vav1m1Btlr/Vav1m1Btlr
C57BL/6J-Vav1m1Btlr
|
abnormal humoral immune response |
J:265128
|
decreased B-1 B cell number |
J:265128
|
decreased CD4-positive, alpha-beta T cell number |
J:265128
|
decreased CD8-positive, alpha-beta T cell number |
J:265128
|
decreased CD8-positive, naive alpha-beta T cell number |
J:265128
|
decreased IgD level |
J:265128
|
decreased IgG level |
J:265128
|
decreased single-positive T cell number |
J:265128
|
decreased T cell number |
J:265128
|
increased central memory CD4-positive, alpha-beta T cell number |
J:265128
|
increased central memory CD8 positive, alpha-beta T cell number |
J:265128
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:265128
|
increased IgM level |
J:265128
|
Vav1m2Btlr/Vav1m2Btlr
C57BL/6J-Vav1m2Btlr
|
decreased B-1 B cell number |
J:265130
|
Vav1M3Btlr/Vav1M3Btlr
C57BL/6J-Vav1M3Btlr
|
decreased IgG level |
J:272527
|
impaired humoral immune response |
J:272527
|
Vav1M4Btlr/Vav1M4Btlr
C57BL/6J-Vav1M4Btlr
|
abnormal CD4-positive T cell differentiation |
J:272528
|
abnormal CD8-positive, alpha-beta T cell differentiation |
J:272528
|
abnormal T cell differentiation |
J:272528
|
decreased B-1 B cell number |
J:272528
|
decreased CD4-positive, alpha-beta T cell number |
J:272528
|
decreased CD8-positive, naive alpha-beta T cell number |
J:272528
|
increased central memory CD4-positive, alpha-beta T cell number |
J:272528
|
increased central memory CD8 positive, alpha-beta T cell number |
J:272528
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:272528
|
increased effector memory CD8-positive, alpha-beta T cell number |
J:272528
|
Vav1M5Btlr/Vav1M5Btlr
C57BL/6J-Vav1M5Btlr
|
decreased CD8-positive, alpha-beta T cell number |
J:272529
|
Vav1tm1Bbd/Vav1+
involves: 129S2/SvPas * C57BL/6J
|
transmission ratio distortion |
J:22517
|
Vav1tm1Bbd/Vav1tm1Bbd
involves: 129S2/SvPas * C57BL/6J
|
embryonic lethality between implantation and somite formation, complete penetrance |
J:22517
|
failure of blastocyst to hatch from the zona pellucida |
J:22517
|
Vav1tm1Tyb/Vav1tm1Tyb
C.129S2-Vav1tm1Tyb
|
abnormal negative T cell selection |
J:79323
|
Vav1tm1Tyb/Vav1tm1Tyb
either: (involves: 129S4/SvJae * 129S8/SvEv) or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)
|
abnormal CD8-positive, alpha-beta T cell physiology |
J:190087
|
abnormal immune system physiology |
J:190087
|
abnormal interleukin-2 secretion |
J:190087
|
abnormal lymphocyte cell number |
J:190087
|
abnormal T cell number |
J:190087
|
decreased double-positive T cell number |
J:190087
|
increased DN2 thymocyte number |
J:190087
|
increased DN3 thymocyte number |
J:190087
|
increased double-negative T cell number |
J:190087
|
Vav1tm1Tyb/Vav1tm1Tyb
involves: 129S2/SvPas
|
abnormal double-negative T cell morphology |
J:79323
|
abnormal T cell physiology |
J:79323,
J:86654
|
decreased double-positive T cell number |
J:79323
|
decreased interferon-gamma secretion |
J:86654
|
decreased interleukin-2 secretion |
J:86654
|
decreased mature B cell number |
J:86654
|
decreased single-positive T cell number |
J:79323
|
decreased T cell proliferation |
J:86654
|
decreased thymocyte number |
J:86654
|
thymus hypoplasia |
J:79323
|
Vav1tm1Tyb/Vav1tm1Tyb
involves: 129S2/SvPas * 129S8/SvEv
|
abnormal T cell physiology |
J:113270
|
decreased CD4-positive, alpha-beta T cell number |
J:113270
|
decreased double-negative T cell number |
J:113270
|
decreased T cell proliferation |
J:113270
|
Vav1tm1Tyb/Vav1tm1Tyb
involves: 129S2/SvPas * C57BL/10 * C57BR/cd
|
abnormal CD4-positive, alpha beta T cell morphology |
J:79323
|
abnormal T cell physiology |
J:128985
|
decreased interleukin-2 secretion |
J:128985
|
decreased T cell proliferation |
J:128985
|
decreased tumor necrosis factor secretion |
J:128985
|
Vav1tm1Tyb/Vav1tm1Tyb
involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd
|
abnormal CD4-positive, alpha beta T cell morphology |
J:113270
|
abnormal negative T cell selection |
J:113270
|
Vav1tm2Bbd/Vav1tm2Bbd
B6.129-Vav1tm2Bbd
|
abnormal CD4-positive T cell differentiation |
J:141390
|
abnormal positive T cell selection |
J:141390
|
abnormal T cell physiology |
J:141390
|
decreased double-positive T cell number |
J:141390
|
decreased interleukin-4 secretion |
J:71161
|
decreased NK T cell number |
J:71161
|
decreased T cell number |
J:141390
|
normal
immune system phenotype |
J:71161
|
impaired natural killer cell mediated cytotoxicity |
J:71161
|
Vav1tm2Bbd/Vav1tm2Bbd
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal B cell number |
J:55647
|
abnormal lymph node cell ratio |
J:69806
|
abnormal response to infection |
J:55647
|
abnormal splenic cell ratio |
J:69806
|
abnormal T cell differentiation |
J:47596
|
abnormal T cell number |
J:47596
|
decreased B cell proliferation |
J:55647,
J:69806
|
decreased B-1 B cell number |
J:55647
|
decreased CD4-positive, alpha-beta T cell number |
J:47596
|
decreased CD8-positive, alpha-beta T cell number |
J:47596
|
decreased IgG1 level |
J:55647
|
decreased IgG2a level |
J:55647
|
decreased IgG3 level |
J:69806
|
decreased IgG level |
J:55647
|
increased double-negative T cell number |
J:47596
|
increased transitional stage B cell number |
J:69806
|
Vav1tm2Bbd/Vav1tm2Bbd
involves: 129S1/Sv * 129X1/SvJ * CD-1
|
abnormal T cell activation |
J:47596
|
abnormal T cell differentiation |
J:47596
|
decreased B-1 B cell number |
J:47596
|
decreased CD4-positive, alpha-beta T cell number |
J:47596
|
decreased CD8-positive, alpha-beta T cell number |
J:47596
|
decreased interleukin-2 secretion |
J:47596
|
decreased T cell proliferation |
J:47596
|
normal
immune system phenotype |
J:47596
|
thymus hypoplasia |
J:47596
|
Vav1tm2Tyb/Vav1tm2Tyb
involves: 129S4/SvJae * 129S8/SvEv
|
abnormal T cell physiology |
J:113270
|
decreased CD4-positive, alpha-beta T cell number |
J:113270
|
decreased double-negative T cell number |
J:113270
|
decreased T cell proliferation |
J:113270
|
Vav1tm2Tyb/Vav1tm2Tyb
involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd
|
abnormal CD4-positive, alpha beta T cell morphology |
J:113270
|
abnormal negative T cell selection |
J:113270
|
Vav1tm3Tyb/Vav1tm3Tyb
involves: 129S4/SvJae * 129S8/SvEv
|
no abnormal phenotype detected |
J:113270
|
Vav1tm4Tyb/Vav1tm4Tyb
either: 129S8.129S4-Vav1tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha-beta T cell physiology |
J:190087
|
abnormal CD8-positive, alpha-beta T cell physiology |
J:190087
|
abnormal immune serum protein physiology |
J:190087
|
abnormal immune system physiology |
J:190087
|
abnormal interleukin-2 secretion |
J:190087
|
abnormal lymphocyte cell number |
J:190087
|
abnormal T cell number |
J:190087
|
abnormal T cell physiology |
J:190087
|
increased circulating interferon-gamma level |
J:190087
|
increased DN2 thymocyte number |
J:190087
|
increased DN3 thymocyte number |
J:190087
|